← Open Payments lookup

KATE MIMKEN: Open Payments

NPI 1912426578 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,673 in 37 payments from 19 companies in 2025. Trend: 2023 $1,912 · 2024 $583 · 2025 $2,673

Consulting: $1,508Food & beverage: $1,165
CompanyPaymentsAmount
Janssen Biotech, Inc.4$908
GlaxoSmithKline, LLC.2$800
GENZYME CORPORATION3$261
BeOne Medicines USA, Inc.2$152
ABBVIE INC.7$140
Celgene Corporation2$50
PFIZER INC.3$50
Incyte Corporation2$50
Azurity Pharmaceuticals, Inc.2$36
Merck Sharp & Dohme LLC1$27

Products named: SARCLISA, BRUKINSA, VENCLEXTA, EPKINLY, REBLOZYL, ELREXFIO, DANZITEN, IMBRUVICA.

Industry payments across CO — which companies pay providers there.